达比加群酯用于非瓣膜病心房颤动患者卒中预防的临床应用建议

被引：59

作者：

中华心血管病杂志编辑委员会血栓栓塞防治循证工作组

机构：

[1] 中华心血管病杂志编辑委员会血栓栓塞防治循证工作组

来源：

中华心血管病杂志 | 2014年 / 03期

关键词：

D O I：

暂无

中图分类号：

R541.75 [];

学科分类号：

摘要：

<正>

引用

页码：188 / 192

页数：5

共 27 条

[1] 中国心房颤动现状的流行病学研究 [J].

周自强 ;

胡大一 ;

陈捷 ;

张仁汉 ;

李奎宝 ;

赵秀丽 .

中华内科杂志, 2004, (07) :15-18

[2] 华法林对中国人心房颤动患者抗栓的安全性和有效性研究 [J].

孙艺红 ;

胡大一 .

中华内科杂志, 2004, (04) :21-23

[3] 中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究 [J].

胡大一 ;

孙艺红 ;

周自强 ;

李奎宝 ;

倪永斌 ;

杨光 ;

孙淑红 ;

李蕾 .

中华内科杂志, 2003, (03) :16-20

[4]

Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis.[J] Providência Rui;Albenque Jean-Paul;Combes Stephane;Bouzeman Abdeslam;Casteigt Benjamin;Combes Nicolas;Narayanan Kumar;Marijon Eloi;Boveda Serge Heart (British Cardiac Society) 2014,

[5]

Safety and Efficacy of Dabigatran Compared to Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: a Meta-Analysis[J] M Shurrab;A Kaoutskaia;B Arouny;I Lashevsky;A Danon;D Newman;N Kansal;S Schulman;J Healey;C Morillo;E Crystal Canadian Journal of Cardiology 2013,

[6]

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies[J] Benjamin A. Steinberg;Vic Hasselblad;Brett D. Atwater;Tristram D. Bahnson;Jeffrey B. Washam;John H. Alexander;James P. Daubert;Jonathan P. Piccini Journal of Interventional Cardiac Electrophysiology 2013,

[7]

Dabigatran Versus Warfarin: Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation[J] Masatsugu Hori;Stuart J. Connolly;Jun Zhu;Li Sheng Liu;Chu-Pak Lau;Prem Pais;Denis Xavier;Sung Soon Kim;Razali Omar;Antonio L. Dans;Ru San Tan;Jyh-Hong Chen;Supachai Tanomsup;Mitsunori Watanabe;Masahide Koyanagi;Michael D. Ezekowitz;Paul A. Reilly;Lars Wallentin;Salim Yusuf Stroke 2013,

[8]

Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis[J] Aref A. Bin Abdulhak;Abdur Rahman Khan;Imad M. Tleyjeh;John A. Spertus;Susan U. Sanders;Kristy E. Steigerwalt;Musa A. Garbati;Reem A. Bahmaid;Alan P. Wimmer Europace 2013,

[9]

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.[J] Heidbuchel Hein;Verhamme Peter;Alings Marco;Antz Matthias;Hacke Werner;Oldgren Jonas;Sinnaeve Peter;Camm A John;Kirchhof Paulus Europace : European pacing; arrhythmias; and cardiac electrophysiology : journal of the working groups on cardiac pacing; arrhythmias; and cardiac cellular electrophysiology of the European Society of Cardiology 2013,

[10]

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation[J] K. Huber;S. J. Connolly;A. Kher;F. Christory;G.‐A. Dan;R. Hatala;R. G. Kiss;B. Meier;B. Merkely;B. Pieske;T. Potpara;J. St?pińska;N. Vene Klun;D. Vinereanu;P. Widimsky Int J Clin Pract 2013,

← 1 2 3 →